ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 254

$1.85M Total Retail Price of All Prescriptions

Rank: 6 out of 254

392 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 2,507 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$138 was the average price of a prescription from this provider, compared to $285 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
VIMPAT 413 46 1 22
RISPERIDONE 278 47 2 20
LYRICA 272 64 3 9
ABILIFY 266 37 4 40
GABAPENTIN 232 36 5 2
TOPIRAMATE 224 0 6 6
ALLOPURINOL 216 29 7 81
BACLOFEN 215 0 8 13
CYMBALTA 215 23 8 14
LEVETIRACETAM 206 14 10 5
LEVOTHYROXINE SODIUM 198 50 11 67
ESCITALOPRAM OXALATE 192 19 12 24
SIMVASTATIN 179 73 13 66
AMITRIPTYLINE HCL 169 51 R 14 32
LACTULOSE 169 21 14 95
TAMSULOSIN HCL 162 17 16 98
OMEPRAZOLE 161 21 17 99
QUETIAPINE FUMARATE 158 21 18 29
PROPRANOLOL HCL 158 37 18 42
LAMOTRIGINE 158 16 18 7
OXCARBAZEPINE 157 23 21 19
MIRTAZAPINE 152 35 22 59
ZOLPIDEM TARTRATE 149 25 23 38
CARBIDOPA-LEVODOPA 145 61 24 1
SPIRIVA 137 0 25 107
WARFARIN SODIUM 134 0 26 109
ZONISAMIDE 131 0 27 36
DICLOFENAC SODIUM 124 20 28 92
SINGULAIR 121 19 29 116
TIZANIDINE HCL 116 0 30 34
METOCLOPRAMIDE HCL 115 0 31 119
AZILECT 112 85 32 21
NAMENDA 112 55 32 4
KETOCONAZOLE 109 0 34 123
FLUTICASONE PROPIONATE 106 0 35 126
METFORMIN HCL 106 16 35 126
CLOPIDOGREL 104 59 37 62
SERTRALINE HCL 103 26 38 16
POLYETHYLENE GLYCOL 3350 101 0 39 130
VESICARE 100 34 40 131
AZITHROMYCIN 98 0 41 132
SAVELLA 98 17 41 132
POTASSIUM CHLORIDE 98 0 41 132
AMANTADINE 97 37 44 30
SUBOXONE 96 0 45 80
AMLODIPINE BESYLATE 93 21 46 136
METOPROLOL SUCCINATE 92 0 47 137
ATORVASTATIN CALCIUM 92 16 47 137
TRAMADOL HCL 91 27 49 41
BUPROPION XL 90 0 50 77
CLONIDINE HCL 86 29 51 142
CRESTOR 84 13 52 109
METHYLPREDNISOLONE 82 20 53 144
COLCRYS 79 11 54 147
NYSTOP 75 0 55 150
SPIRONOLACTONE 73 25 56 152
LOVAZA 70 0 57 85
OXYCODONE HCL-ACETAMINOPHEN 70 19 S2 57 48
HYDROXYZINE HCL 69 0 R 59 155
PLAVIX 69 37 59 61
PRIMIDONE 68 31 61 10
FUROSEMIDE 68 0 61 156
LIDODERM 67 0 63 65
AMITIZA 67 20 63 159
DANTROLENE SODIUM 65 0 10 65 161
MELOXICAM 62 15 66 88
LEXAPRO 62 13 66 79
PROAIR HFA 61 0 68 167
AMOX TR-POTASSIUM CLAVULANATE 61 14 68 167
LITHIUM CARBONATE 60 0 70 46
DESOXIMETASONE 60 18 70 170
DIVALPROEX SODIUM ER 60 0 70 12
ONGLYZA 59 20 73 171
TRAZODONE HCL 59 0 73 44
LEVOCETIRIZINE DIHYDROCHLORIDE 58 0 75 172
HYDROCODONE BIT-IBUPROFEN 58 11 S3 75 105
HYDROCHLOROTHIAZIDE 55 0 77 174
BENZTROPINE MESYLATE 54 17 R 78 18
CARISOPRODOL 54 0 R 78 118
OLANZAPINE 52 13 80 37
NEXIUM 52 0 80 125
ADVAIR DISKUS 52 0 80 181
MONTELUKAST SODIUM 51 0 83 182
EXELON 51 29 83 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.